Nov. 29, 2018 – “FDA is warning that rare but serious cases of stroke and tears in the lining of arteries in the head and neck have occurred in patients with multiple sclerosis (MS) shortly after they received Lemtrada (alemtuzumab),” the agency said. “These problems can lead to permanent disability and even death.”
Free Confidential Lawsuit Evaluation: If you or a loved one has been injured by the side effects of Lemtrada (alemtuzumab), you should contact our law firm immediately. You may be entitled to compensation by filing a suit against the manufacturer and our lawyers can help.
What’s the Problem?
“Patients or their caregivers should seek emergency treatment as soon as possible if the patient experiences signs or symptoms of a stroke or tears in the lining of the head and neck arteries, called arterial dissection,” FDA said.
Arterial Dissection Symptoms
- Sudden numbness or weakness in the face, arms, or legs, especially if it occurs on only one side of the body
- Sudden confusion, trouble speaking, or difficulty understanding speech
- Sudden trouble seeing in one or both eyes
- Sudden trouble with walking, dizziness, or loss of balance or coordination
- Sudden severe headache or neck pain
What is Lemtrada?
Lemtrada is a disease-modifying therapy for people with relapsing forms of multiple sclerosis. The drug is initially administered intravenously (IV) for 5 consecutive days, and for 3 consecutive days one year later. Due to its risky safety profile, the Prescribing Information (PDF) states that Lemtrada should generally only be used on patients who have had poor responses to 2 or more other multiple sclerosis therapies.
According to the Mayo Clinic, signs and symptoms of a stroke may include:
- Trouble with speaking and understanding
- Paralysis or numbness of the face, arm or leg
- Sudden numbness, weakness or paralysis in your face, arm or leg
- One side of your mouth may droop when you try to smile
- Trouble with seeing in one or both eyes
- Trouble with walking
- Sudden dizziness, loss of balance or loss of coordination
Can I File a Suit?
Only a qualified attorney can determine whether you are eligible to file a lawsuit against Sanofi, the maker of Lemtrada, which is why we are currently offering free case evaluations. Simply fill out the confidential evaluation form below to contact our law firm now.
Most cases involving pharmaceuticals allege that a drug was sold with design, manufacturing, and/or marketing defects, which typically refers to a company’s failure to warn of a certain side effect. In the case of Lemtrada, our attorneys suspect that patients may be able to take legal action in light of claims that Sanofi failed to adequately warn doctors and patients about the risk of stroke and arterial dissection.
How Can Filing a Complaint Help Me?
By filing a lawsuit against the makers of Lemtrada, you may be entitled to collect compensation for all current and future medical expenses related to the treatment of your injury, as well as for damages for pain and suffering. Additionally, filing a lawsuit can help hold the drug’s manufacturer accountable for releasing an allegedly defective drug into the marketplace, and to discourage other pharmaceutical companies from engaging in similar conduct.
Do I Have a Lemtrada Lawsuit?
The Pharmaceutical Litigation Group at our law firm is an experienced team of trial lawyers that focus on the representation of plaintiffs in Lemtrada lawsuits. We are handling individual litigation nationwide and currently accepting new stroke and blood vessel wall tear cases in all 50 states.
Free Case Evaluation: Again, if you or a loved one has been injured by the side effects of Lemtrada (alemtuzumab), you should contact our law firm immediately. You may be entitled to compensation by filing a suit and we can help.